Last Updated: May 20, 2026

Drug Price Trends for ISOPROPYL RUBBING ALCOHOL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ISOPROPYL RUBBING ALCOHOL

Average Pharmacy Cost for ISOPROPYL RUBBING ALCOHOL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ISOPROPYL RUBBING ALCOHOL 70% 68599-2302-06 0.04515 ML 2026-01-21
ISOPROPYL RUBBING ALCOHOL 70% 68599-2302-06 0.04534 ML 2025-12-17
ISOPROPYL RUBBING ALCOHOL 70% 68599-2302-06 0.04440 ML 2025-11-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market analysis and price projections for isopropyl rubbing alcohol (isopropanol, IPA)

Last updated: April 24, 2026

What is the market structure for isopropyl rubbing alcohol (IPA)?

Isopropyl rubbing alcohol is isopropanol (CAS 67-63-0) marketed for personal care, disinfecting, and consumer “rubbing alcohol” end uses. In commerce it typically tracks the bulk IPA chemical market, with price formation driven by:

  • Upstream propylene and co-product supply (IPA is produced from propylene via hydration/isomerization routes)
  • Industrial demand cycles (solvents, cleaning, coatings)
  • Consumer and healthcare pull (hand-sanitizer and surface disinfecting)
  • Logistics and local distribution (bottled retail vs bulk industrial supply)
  • Regulatory and denaturant/spec requirements for potable-use-adjacent grades (outside strict drinking alcohol rules)

Typical supply and product segmentation

Markets separate IPA by grade (examples below) and by channel:

Segment Common spec basis (indicative) Typical channel
Industrial IPA General solvent grades Industrial buyers, contract packaging
Electronics/semiconductor IPA Ultra-high purity Semiconductor materials suppliers
Healthcare/consumer “rubbing alcohol” Denatured and/or packaged for retail Pharmacies, big-box retail, online
Bulk IPA (totes/drums) Bulk chemical Distributors and contract cleaners

For price analysis, the key practical distinction is that consumer “rubbing alcohol” bottle prices do not move 1:1 with bulk chemical, because packaging, distribution, margins, and competing retail chemistries (ethanol-based sanitizers, wipes) create a lag and a markup band.

Which price benchmarks matter for projections?

For investment and procurement decisions, the most decision-relevant benchmarks are:

  1. Bulk IPA (spot/contract) price indexes for chemical buyers
  2. Regional wholesale distributor pricing for bottled rubbing alcohol
  3. Retail shelf pricing (to measure how retail absorbs bulk moves)
  4. Exchange-rate and freight effects where supply relies on imports

Because “isopropyl rubbing alcohol” is an everyday commodity rather than a single patented drug product, there is no single “drug price.” Price forecasts must be benchmarked to IPA bulk and retail pack economics.

How do recent market dynamics typically move IPA prices?

IPA price direction in most periods is set by:

  • Propylene cost and availability (drives marginal IPA economics)
  • Regional production capacity utilization and turnarounds
  • Demand rotation between IPA and alternative solvents (MEK, ethanol, n-propanol, blends)
  • Ethanol and sanitizer substitution during public health spikes
  • Inventory cycles (bulk chemical stocks build or draw based on contract coverage)

During high sanitizer/disinfectant demand, consumer-pack prices can decouple upwards from bulk for short windows due to packaging constraints and distribution bottlenecks. After that, retail tends to revert toward bulk-linked margins.

What is the demand outlook for rubbing alcohol/IPA?

Demand is structurally supported by:

  • Ongoing disinfecting and cleaning use in healthcare and facility maintenance
  • Electronics cleaning and materials processing (for high-purity IPA)
  • Solvent and chemical intermediate use in coatings and manufacturing

Demand volatility is strongest in periods with:

  • Consumer surges tied to respiratory virus seasons
  • Sudden changes in sanitizer formulation guidance and availability of substitutes

Price projections: base case, bull case, bear case (next 12-24 months)

Below are scenario-based price projections designed for actionable planning. They use a “bulk-to-retail” framing: bulk IPA drives the ceiling, while retail packaging and distribution determine realized consumer pricing bands.

Assumptions (scenario logic, not a disclaimer)

  • Retail rubbing alcohol pricing follows bulk IPA with a lag of weeks to a few months.
  • Bottled consumer pricing includes relatively stable overhead (bottles, labels, fulfillment) but margins can compress/expand depending on supply tightness.
  • Taxes and alcohol denaturing constraints are treated as stable for the forecast horizon.

Projection table (index-based bands)

The market commonly quotes IPA in $ per metric ton (MT) for bulk and in $/bottle for retail. Without specifying a single retailer SKU and geography, the most robust approach is to give relative movement bands anchored to the current market level for your planning base.

Scenario Bulk IPA direction Consumer “rubbing alcohol” price movement (typical lag) Planning band (12-24 months)
Bear (demand soft + supply normal) Down modestly Down less than bulk (margin stickiness) Bulk: -8% to -15%; Retail: -4% to -10%
Base (balanced supply/demand) Sideways to slight drift Retail moves within a narrow band Bulk: -2% to +6%; Retail: -1% to +4%
Bull (demand rebound + supply constrained) Up Retail up more than bulk early, then stabilizes Bulk: +8% to +20%; Retail: +5% to +15%

What would trigger each scenario in practice?

Bear triggers

  • Higher utilization and/or incremental regional capacity
  • Reduced disinfectant pull and faster substitution back to non-alcohol cleaners
  • Competitive pricing from alternative solvents

Bull triggers

  • Propylene tightness or sudden feedstock price spikes
  • Export constraints or plant outages in key producing regions
  • Renewed consumer purchasing spikes that outstrip bottling capacity

Retail and procurement implications

Retail (bottled rubbing alcohol)

Retail pricing tends to:

  • Move in waves during seasonal demand peaks
  • Reprice faster when supply is constrained (fast upward), but may fall slower when inventory clears

Procurement (bulk or distributor-packed)

For industrial buyers, procurement pricing:

  • Tracks bulk IPA indexes more closely
  • Is more sensitive to contract coverage, freight, and grade purity

How to model “price projections” for a specific budget

A practical budgeting model uses a two-layer structure:

  1. Bulk price forecast (the chemical market)
  2. Pack and channel conversion factor (bottling, logistics, margins)

Use this structure:

  • Retail price = Bulk IPA price × conversion factor (markup + packaging + logistics)
  • Keep the conversion factor constant in the base case; allow modest factor compression in bears and factor expansion in bulls when bottling/distribution is tight.

Competitive substitution pressure

Even when IPA prices rise, demand for “rubbing alcohol” can partially shift to:

  • Ethanol-based disinfectants
  • Hydrogen peroxide wipes
  • Alcohol-free or lower-alcohol cleaning products where regulations and guidance permit

This substitution usually limits extreme sustained upside for retail, even if bulk remains firm.

Regulatory and labeling effects

For “rubbing alcohol,” the market is shaped by:

  • Denaturing or formulation requirements for intended use
  • Local labeling rules for consumer safety claims

These effects typically change by jurisdiction and product category, not by IPA chemistry itself, and they tend to change the conversion factor more than the bulk IPA price.

Key takeaways

  • Isopropyl rubbing alcohol is a commodity IPA market product; pricing is dominated by bulk IPA dynamics with added lag and markup from packaging and distribution.
  • Use scenario-based projections rather than point estimates: Bear: Bulk -8% to -15%, Retail -4% to -10%; Base: Bulk -2% to +6%, Retail -1% to +4%; Bull: Bulk +8% to +20%, Retail +5% to +15%.
  • The most important forward indicators are propylene/feedstock pricing, regional capacity utilization, and seasonal disinfectant demand spikes that can temporarily decouple retail from bulk.

FAQs

1) Is “isopropyl rubbing alcohol” priced like a patented drug?

No. It is priced like an industrial/consumer chemical product. Market pricing tracks bulk IPA plus channel-specific packaging, logistics, and margin.

2) Why can retail prices move differently from bulk IPA?

Retail includes bottling, labels, distribution, and retailer margin. During supply stress, packaging and distribution constraints can create a faster and larger retail increase than bulk. Retail can fall slower when inventory is constrained or when replenishment costs remain elevated.

3) What matters most for forecasting direction?

Feedstock and supply: propylene cost, plant outages, utilization, and logistics. On the demand side, disinfectant/healthcare seasonal demand and substitution effects matter.

4) Can substitution cap price upside?

Yes. Alternative disinfectants and lower-alcohol formats can absorb part of the demand if IPA becomes expensive, especially at retail where consumers can switch products.

5) How should procurement teams set budgets?

Budget using a bulk-to-retail conversion factor and model bear/base/bull bands for bulk IPA. Then apply a conservative lag and conversion-factor adjustment for bottling and distribution.


References

[1] U.S. Environmental Protection Agency (EPA). Chemical and product information for isopropanol (CAS 67-63-0).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.